Login
Evidence Feed
About
Diagnostics
New
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
BIOMARKER:
KIR2DL3 overexpression
i
Other names:
Killer Cell Immunoglobulin Like Receptor, Two Ig Domains And Long Cytoplasmic Tail 3, CD158B2, Killer Cell Immunoglobulin-Like Receptor 2DL3, P58 Natural Killer Cell Receptor Clone CL-6, CD158 Antigen-Like Family Member B2, Killer Inhibitory Receptor Cl 2-3, P58 NK Receptor CL-6, KIR-023GB, KIRCL23, NKAT-2, NKAT2, P58, Killer Cell Immunoglobulin-Like Receptor, Two Domains, Short Cytoplasmic Tail, 5, Killer Cell Immunoglobulin-Like Receptor, Two Domains, Long Cytoplasmic Tail, 3, Killer Cell Immu
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Entrez ID:
3804
Associations
News
Trials
VERI cancer hierarchy
Reset Filters
KIR2DL3 overexpression
Biliary Tract Cancer
KIR2DL3 overexpression
Biliary Tract Cancer
camrelizumab + rivoceranib
Resistant: C3 – Early Trials
camrelizumab + rivoceranib
Resistant
:
C3
camrelizumab + rivoceranib
Resistant: C3 – Early Trials
camrelizumab + rivoceranib
Resistant
:
C3
^
^
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.